Pathological work-up and assessment of sentinel lymph nodes in melanoma patients;Melanoma malignumos betegek sentinel nyirokcsomóinak patológiai vizsgálata

Magyar Onkologia

Volumn 47, Issue 1, 2003, Pages 51-57

  Gábor, Cserni ^a  

^a Bács Kiskun Megyei Önkormányzat Kórháza ^*  (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE; MELANOMA; PATHOLOGY; REVIEW; SENTINEL LYMPH NODE BIOPSY; SKIN TUMOR;

HUMANS; IMMUNOHISTOCHEMISTRY; LYMPH NODES; MELANOMA; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS;

EID: 0042702024     PISSN: 00250244     EISSN: 20600399     Source Type: Journal    
DOI: None     Document Type: Article

References (67)

1. Ackerman AB. Discordance among expert pathologists in diagnosis of melanocytic neoplasms. Hum Pathol 27:1115-1116, 1996
2. Baisden BL, Askin FB, Lange JR, et al. HMB-45 immunohistochemical staining of sentinel lymph nodes: a specific method for enhancing detection of micrometastases in patients with melanoma. Am J Surg Pathol 24:1140-1146, 2000
3. Balch CM, Soong SJ, Bartolucci AA, et al. Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger. Ann Surg 224:255-266, 1996
4. Balch CM, Soong SJ, Murad TM, et al. A multifactorial analysis of melanoma: III Prognostic factors in melanoma patients with lymph node metastases (stage II). Ann Surg 193:377-388, 1981
5. Bautista NC, Cohen S, Anders KH. Benign melanocytic nevus cells in axillary lymph nodes. A prospective incidence and immunohistochemical study with literature review. Am J Clin Pathol 102:102-108, 1994
6. Blaheta HJ, Ellwanger U, Schittek B, et al. Examination of regional lymph nodes by sentinel node biopsy and molecular analysis provides new staging facilities in primary cutaneous melanoma. J Invest Dermatol 114:637-642, 2000
7. Blaheta HJ, Paul T, Sotlar K, et al. Detection of melanoma cells in sentinel lymph nodes, bone marrow and peripheral blood by a reverse transcription-polymerase chain reaction assay in patients with primary cutaneous melanoma: association with Breslow's tumour thickness. Br J Dermatol 145:195-202, 2001
8. Bostick PJ, Morton DL, Turner RR, et al. Prognostic significance of occult metastases detected by sentinel lymphadenectomy and reverse transcriptase-polymerase chain reaction in early-stage melanoma patients. J Clin Oncol 17:3238-3244, 1999
9. Breslow A. Thickness, cross sectional areas, and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg 172:902-908, 1970
10. Carson KF, Wen DR, Li PX, et al. Nodal nevi and cutaneous melanoma. Am J Surg Pathol 20:834-840, 1996
11. Cascinelli N, Morabito A, Santinami M, et al. Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: a randomised trial. Lancet 351:793-796, 1998
12. Cibull ML. Handling sentinel lymph node biopsy specimens. A work in progress. Arch Pathol Lab Med 123:620-621, 1999
13. Clark WH Jr, From L, Bernardino E, et al. The histogenesis and biologic behavior of primary human malignant melanomas of the skin. Cancer Res 29:705-726, 1969
14. Cochran AJ. Surgical pathology remains pivotal in the evaluation of sentinel lymph nodes. Am J Surg Pathol 23:1169-1172, 1999
15. Cochran AJ, Balda BR, Starz H, et al. The Augsburg Consensus. Techniques of lymphatic mapping, sentinel lymphadenectomy, and completion lymphadenectomy in cutaneous malignancies. Cancer 89:236-241, 2000
16. Cochran AJ, Huang RR, Guo J, et al. Current practice and future directions in pathology and laboratory evaluation of the sentinel node. Ann Surg Oncol 8(Suppl 9):13S-17S, 2001
17. Cochran AJ, Morton DL, Stern S, et al. Sentinel lymph nodes show profound downregulation of antigenpresenting cells of the paracortex: implications for tumor biology and treatment. Mod Pathol 14:604-608, 2001
18. Creager AJ, Shiver SA, Shen P, et al. Intraoperative evaluation of sentinel lymph nodes for metastatic melanoma by imprint cytology. Cancer 94:3016-3022, 2002
19. Cserni G. Complete step sectioning of axillary sentinel lymph nodes in patients with breast cancer. Analysis of two different step sectioning and immunohistochemistry protocols in 246 patients. J Clin Pathol, in press.
20. Cserni G. Mapping metastases in sentinel lymph nodes of breast cancer. Am J Clin Pathol 113:351-354, 2000
21. Cserni G. Misidentification of an axillary sentinel lymph node due to anthracosis. Eur J Surg Oncol 24:168, 1998
22. Cserni G, Péley G, Dubecz S. Sentinel Node 2000 (2nd International Sentinel Node Congress), Santa Monica, CA, USA, 2000. december 1-4. Magyar Onkológia 45:443-444, 2001
23. Cserni G, Péley G, Dubecz S. Sentinel Node 2000 (2nd International Sentinel Node Congress), Santa Monica, CA, USA, 2000. december 1-4. Orv Hetil 142:540-541, 2001
24. Diaz LK, Wiley EL, Venta LA. Are malignant cells displaced by large-gauge needle core biopsy of the breast. AJR 173:1303-1313, 1999
25. Essner R, Kojima M. Surgical and molecular approaches to the sentinel lymph nodes. Ann Surg Oncol 8(9 Suppl):31S-34S, 2001
26. Farkas E, Liszkay G, Péley G, et al. Melanoma malignum sentinel nyirokcsomójának eltávolításában szerzett kezdeti tapasztalataink. Magyar Sebészet 53:61-66, 2000
27. Fleming ID, Cooper JS, Henson DE, et al, eds. AJCC cancer staging manual, 5. kiadás, Philadelphia: Lippincott-Raven, 1997
28. Fontaine D, Parkhill W, Greer W, et al. Nevus cells in lymph nodes: an association with congenital cutaneous nevi. Am J Dermatopathol 24:1-5, 2002
29. Frisman D. Immuno Query 2002. 10. 22.
30. Gershenwlad JE, Colome MI, Lee JE, et al. Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma. J Clin Oncol 16:2253-2260, 1998
31. Gershenwald JE, Thompson W, Mansfield PF, et al. Multiinstitutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J Clin Oncol 17:676-683, 1999
32. Gibbs JF, Huang PP, Zhang PJ, et al. Accuracy of pathologic techniques for the diagnosis of metastatic melanoma in sentinel lymph nodes. Ann Surg Oncol 6:699-704, 1999
33. Haigh PI, Lucci A, Turner RR, et al. Carbon dye histologically confirms the identity of sentinel nodes in cutaneous melanoma. Cancer 92:535-541, 2001
34. Jarrett P, Thomson W, MacKie RM. Immunohistochemistry and sentinel node biopsy in melanoma: the use of tyrosinase and Melan-A. Br J Dermatol 141:361-362, 1999
35. Kelley SW, Cockerell CJ. Sentinel lymph node biopsy as an adjunct to management of histologically difficult to diagnose melanocytic lesions: a proposal. J Am Acad Dermatol 42:527-530, 2000
36. Koopal SA, Tiebosch ATMG, Albertus Piers DA, et al. Frozen section analysis of sentinel lymph nodes in melanoma patients. Cancer 89:1720-1725, 2000
37. Leong SPL, Achtem TA, Habib FA, et al. Discordancy between clinical predictions vs lymphoscintigraphic and intraoperative mapping of sentinel lymph node drainage of primary melanoma. Arch Dermatol 135:1472-1476, 1999
38. Leong SP, Peng M, Zhou YM, et al. Cytokine profiles of sentinel lymph nodes draining the primary melanoma. Ann Surg Oncol 9:82-87, 2002
39. Liszkay G, Farkas E, Péley G, et al. Preoperatív limfoszcintigráfiával végrehajtott sentinel nyirokcsomó mutétek melanoma malignumban. Magyar Onkológia 44:141-143, 2000
40. Lohmann CM, Coit DG, Brady MS, et al. Sentinel lymph node biopsy in patients with diagnostically controversial spitzoid melanocytic tumors. Am J Surg Pathol 26:47-55, 2002
41. Lukowsky A, Bellmann B, Ringk A, et al. Detection of melanoma micrometastases in the sentinel lymph node and in nonsentinel nodes by tyrosinase polymerase chain reaction. J Invest Dermatol 113:554-559, 1999
42. Meyer JS. Sentinel lymph node biopsy: strategies for pathologic examination of the specimen. J Surg Oncol 69:212-218, 1998
43. Méhes G, Witt A, Kubista E, et al. Circulating breast cancer cells are frequently apoptotic. Am J Pathol 159:17-20, 2001
44. Moehrle MW, Blaheta HJ, Ruck P. Tattoo pigment mimics positive sentinel lymph node in melanoma. Dermatology 203:342-344, 2001
45. Morton DL, Wen DR, Wong J, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 127:392-399, 1992
46. Oláh J, Dobozy A. A melanoma malignum új TNM beosztása. Borgyógy Venerol Szle 78:49-50, 2002
47. Oláh J, Gyulai R, Varga J, et al. Orszemnyirokcsomó biopsziával szerzett tapasztalataink melanoma malignumban. LAM 11:536-541, 2001
48. Orosz Zs. A melanoma malignum pathologiai diagnózisának buktatói. Magyar Onkológia 47:27-39, 2003
49. Orosz Zs. Melan-A/Mart-1 expression in various melanocytic lesions and in non-melanocytic soft tissue tumours. Histopathology 34:517-525, 1999
50. Palmieri G, Ascierto PA, Cossu A, et al. Detection of occult melanoma cells in paraffin-embedded histologically negative sentinel lymph nodes using a reverse transcriptase polymerase chain reaction assay. J Clin Oncol 19:1437-1443, 2001
51. Péley G, Farkas E, Mátrai Z, et al. A sebészet szerepe a melanoma malignum kezelésében. Magyar Onkológia 47:69-77, 2003
52. Péley G, Sinkovics I, Liszkay G, et al. Az intraoperatív gamma-próba által vezérelt orszem nyirokcsomó- biopszia jelentosége a melanoma malignum és az emlorák kezelésében. Orv Hetil 140:2331-2338, 1999
53. Shidham VB, Qi DY, Acker S, et al. Evaluation of micrometastases in sentinel lymph nodes of cutaneous melanoma: higher diagnostic accuracy with Melan-A and MART-1 compared with S-100 protein and HMB-45. Am J Surg Pathol 25:1039-1046, 2001
54. Sobin LH, Wittekind Ch, eds. UICC TNM classification of malignant tumours, 5. kiadás, New York: John Wiley and Sons, 1997
55. Sobin LH, Wittekind Ch, eds. UICC TNM classification of malignant tumours, 6. kiadás, New York: John Wiley and Sons, 2002
56. Starz H, De Donno A, Balda BR. The Augsburg experience: histological aspects and patient outcomes. Ann Surg Oncol 8(Suppl 9):48S-51S, 2001
57. Starz H, Gerstel C, Bachter D, et al. Two simple morphometric parameters permit a clinically relevant staging of the sentinel node metastases in malignant melanoma and merkel cell carcinoma. Eur J Nucl Med 26(Suppl):S68, 1998
58. Stojadinovic A, Allen PJ, Clary BM, et al. Value of frozensection analysis of sentinel lymph nodes for primary cutaneous malignant melanoma. Ann Surg 235:92-98, 2002
59. Tarján M. Orszem nyirokcsomó-biopszia Magyarorszá gon. A sebészi onkológia forradalmi újítá sának hazai eredményei. Magyar Onkológia 46:315-321, 2002
60. Thompson JF, Uren RF, Shaw HM, et al. Location of sentinel lymph nodes in patients with cutaneous melanoma: new insights into lymphatic anatomy. J Am Coll Surg 189:195-204, 1999
61. Török L, Mari B, Fórizs A, et al. A szentinel nyirokcsomó vizsgálatának jelentosége melanoma malignumban. Elso tapasztalatok. Orv Hetil 139:1339-1341, 1998
62. Török L, Károlyi Z, Kádár L, et al. A peritumorális nyirokcsomó-szcintigráfia jelentosége melanoma malignumban szenvedo betegeken. Orv Hetil 128:1631-1635, 1987
63. van Diest PJ. Histopathological workup of sentinel lymph nodes: how much is enough? J Clin Pathol 52:871-873, 1999
64. van Diest P, Peterse HL, Borgstein PJ, et al. Pathological investigation of sentinel lymph nodes. Eur J Nucl Med 26(Suppl):S43-49, 1999
65. Wrightson WR, Wong SL, Edwards MJ, et al. Reverse transcriptase- polymerase chain reaction (RT-PCR) analysis of nonsentinel nodes following completion lymphadenectomy for melanoma. J Surg Res 98:47-51, 2001
66. Yu LL, Flotte TJ, Tanabe KK, et al. Detection of microscopic melanoma metastases in sentinel lymph nodes. Cancer 86:617-627, 1999
67. Zervos EE, Burak WE Jr. Lymphatic mapping in solid neoplasms: state of the art. Cancer Control 9:189-202, 2002